Ụgwọ ọrụ anyị na-ebelata ọnụ ahịa ire ere, otu ndị na-enweta ego dị ike, QC pụrụ iche, ụlọ ọrụ siri ike, ọrụ kacha mma maka mmadụ - anụ ahụ - ngwa,ihe mejupụtara oct, ngwa microsomes akpa ume, Ngwa iche iche PBMC, ngwa PBMC oke. Ugbu a, anyị amatala mmekọrịta kwụ ọtọ na ogologo nzukọ na ndị ahịa si North America, Western Europe, Africa, South America, karịa mba na mpaghara 60. Ụlọ ọrụ anyị na-anakọta echiche ọhụrụ, njikwa mma siri ike, ọrụ nsochi ọrụ zuru oke, ma na-agbasosi ike ime ihe ngwọta dị elu. Azụmahịa anyị chọrọ "ịkwụwa aka ọtọ na ntụkwasị obi, ọnụahịa dị mma, onye ahịa mbụ", yabụ anyị meriri ntụkwasị obi nke ọtụtụ ndị ahịa! Ọ bụrụ na ị nwere mmasị na ihe na ọrụ anyị, biko egbula oge ịkpọtụrụ anyị!Ngwa anụ anụ enwe, enwe serum kit, ngwa ngwa PBMC, akpa PBMC ngwa.
SOT nke iri isii na atọ kwụsịrị n'ụzọ zuru oke, obi ụtọ nke IPHASE-US adịghị akwụsị! Nzukọ kwa afọ nke 63 nke American Society of Toxicology e mere nke ọma site na Machị 10-14, 2024, na
IPHASE, dị ka onye ndu na ndu reagents maka in vitro nnyocha nke ọhụrụ ọgwụ, na-aga n'ihu na-ewebata elu - ọgwụgwụ nnyocha reagents n'ọtụtụ ubi na ụdị dabere na afọ nke nnyocha na mmepe ahụmahụ.
Okwu mmalite nke ọgwụ mRNA Messenger RNA (mRNA) bụ usoro nucleotides nke na-etinye protein, na cytoplasm na-enwe ike iji organelles gosipụta protein etinyere. ọgwụ mRNA bụ kemi
Ụdị nyocha PDC in vitro ADME PDC na-eburu n'uche njirimara nke ma nnukwu ma obere ụmụ irighiri ihe. Ya mere, in vitro ADME nyocha na ya kwesịrị iburu n'uche peptides homing, njikọ
N'oge na-adịbeghị anya, IPHASE, yana njikọ Perelman School of Medicine na University of Pennsylvania, dere otu isiokwu na akwụkwọ akụkọ Antibody Therapeutics (IF=4.56) nke akpọrọ "Development of a